CD Formulation news

As a contract research and development biotechnology firm, CD Formulation establishes new benchmarks for health care product development by delivering extensive product formulation services. From initial design to final packaging, the integrated service portfolio

CD Formulation, a leading force in biotechnology research and development, is at the forefront of revolutionizing transdermal delivery systems. As the demand for non-invasive, efficient drug delivery systems grows, CD Formulation has announced its abilities in providing a few transdermal delivery enhancement technologies.

Transdermal Delivery: Overcoming Natural Bar

With the New Year holiday just around the corner, CD Formulation is delighted to announce a limited-time promotional offer for industries seeking innovative solutions in pharmaceutical, cosmetic, and healthcare product development. From November 15, 2024, to January 5, 2025, clients can benefit from a substantial 5%-15% discount on all products and services provided by CD Formulation. This move aims to express sincere gratitude for the continued support and fruitful collaborations over the pa

CD Formulation, a leading contract research and development biotechnology company, is making strides in the realm of oral thin film manufacturing technologies. As a pioneer in drug delivery innovation, the company specializes in crafting cutting-edge oral thin films, demonstrating remarkable expertise across a myriad of formulation techniques. These oral thin film manufacturing methods a

In the rapidly evolving landscape of pharmaceutical innovations, CD Formulation emerges as a key player, offering customized drug conjugates services that cater to the rising demands for advanced drug development. Specializing in complex biologic formulations, Biologics & Biosimilars service team of CD Formulation is re